Kalypsys' Series B Round

Kalypsys raised a round of funding on August 21, 2004.

Kalypsys is a drug discovery company using a cellular ultra high-throughput system to carry out massive drug screening in cellular models of human disease and toxicology.…

Articles about Kalypsys' Series B Round: